OligonukleotideAntisense oligonucleotides for therapy of cystic fibrosis. Inhibition of sodium absorption mediated by ENaC in nasal epithelial cells;Antisense-Oligonukleotide zur Therapie der Mukoviszidose. Inhibition der ENaC-vermittelten Natriumabsorption in humanen Nasenepithelzellen

HNO

Volumn 57, Issue 11, 2009, Pages 1106-1112

  Sobczak, K ^a   Bangel Ruland, N ^a   Semmler, J ^a   Lindemann, H ^b   Heermann, R ^c   Weber, W M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

^c HNO Zentrum Muensterland   (Germany)

Author keywords

Airways; Antisense oligonucleotides; Cystic fibrosis; ENaC; Na+ hyperabsorption

Indexed keywords

AMILORIDE; ANTISENSE OLIGONUCLEOTIDE; EPITHELIAL SODIUM CHANNEL; SODIUM; SODIUM CHANNEL BLOCKING AGENT;

ARTICLE; CELL CULTURE; CYSTIC FIBROSIS; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NOSE MUCOSA; PATHOPHYSIOLOGY; WESTERN BLOTTING;

AMILORIDE; BLOTTING, WESTERN; CELLS, CULTURED; CYSTIC FIBROSIS; EPITHELIAL SODIUM CHANNEL; HUMANS; MICROSCOPY, FLUORESCENCE; NASAL MUCOSA; OLIGORIBONUCLEOTIDES, ANTISENSE; SODIUM; SODIUM CHANNEL BLOCKERS; TRANSFECTION;

EID: 70449527440     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-009-1957-5     Document Type: Article

References (21)

1. Achenbach TV, Brunner B, Heermeier K (2003) Oligonucleotide-based knockdown technologies: antisense versus RNA interference. Chembiochem 4:928-935. doi:10.1002/cbic.200300708.
2. Akhtar S (1998) Antisense technology: selection and delivery of optimally acting antisense oligonucleotides. J Drug Target 5:225-234.
3. Akhtar S, Hughes MD, Khan A et al (2000) The delivery of antisense therapeutics. Adv Drug Deliv Rev 44:3-21. doi:10.1016/S0169-409X(00)00080-6.
4. Bangel N, Dahlhoff C, Sobczak K et al (2008) Upregulated expression of ENaC in human CF nasal epithelium. J Cyst Fibros 7:197-205. doi:10.1016/j.jcf.2007.07.012.
5. Blank U, Glanz H, Eistert B et al (1996) Benzamil und Mukoviszidose: Primärkultur der Nasenschleimhaut als elektrophysiologisches In-vitro-Modell. HNO 44:172-177.
6. + absorption and reversible block by phenamil. Pflügers Arch -Europ. J Physiol 434:19-24.
7. Carroll TP, Schwiebert EM, Guggino WB (1993) CFTR: structure and function. Cell Physiol Biochem 3:388-399. doi:10.1159/000154700.
8. Coutelle C, Bigger B (2001) Gene therapy of cystic fibrosis; review of completed clinical stud. Internist (Berl) 42:1346. doi:10.1007/s001080170056.
9. Crooke ST (2004) Antisense strategies. Curr Mol Med 4:465-487. doi:10.2174/1566524043360375.
10. Gruenert DC, Finkbeiner WE, Widdicombe JH (1995) Culture and transformation of human airway epithelial cells. Am J Physiol 268:L347-L360.
11. Hofmann T, Stutts MJ, Ziersch A et al (1998) Effects of topically delivered benzamil and amiloride on nasal potential difference and sodium absorption in cystic fibrosis respiratory epithelium. Am J Respir Crit Care Med 157:1844-1849.
12. Knowles MR, Carson JL, Collier AM, Boucher RC (1981) Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am Rev Respir Dis 124:484-490.
13. + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10:487-493. doi:10.1038/nm1028.
14. Quinton PM (1999) Physiological basis of cystic fibrosis: a historical perspective. Physiol Rev 79:S3-S22.
15. Rückes-Nilges C, Glanz H, Weber U et al (1999) Ionentransporte über die Nasen- und Nasennebenhöhlenschleimhaut bei Mukoviszidose und chronischer Sinusitis. HNO 47:157-166. doi:10.1007/s001060050375.
16. - secretion in non-cystic fibrosis and cystic fibrosis human nasal epithelium. Cell Physiol Biochem 9:1-11. doi:10.1159/000016298.
17. Smith JJ, Travis SM, Greenberg EP, Welsh MJ (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236. doi:10.1016/S0092-8674(00)81099-5.
18. Stein CA (1996) Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotides. Chem Biol 3:319-323. doi:10.1016/S1074-5521(96)90113-1.
19. Tomkiewicz RP, App EM, Zayas JG et al (1993) Amiloride inhalation therapy in Cystic fibrosis. Am Rev Respir Dis 148:1002-1007.
20. Wagner RW (1994) Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335. dosi:10.1038/372333a0.
21. Wagner RW, Matteucci MD, Grant D et al (1996) Potent and selective inhibition of gene expression by an antisense heptanucleotide. Nat Biotechnol 14:840-844. doi:10.1038/nbt0796-840.